IGFBP2 and systemic inflammatory response syndrome: In our study, the 24 septic COVID-19 patients exhibited plasma IGFBP-2 levels comparable to the SIRS/sepsis patients without a SARS-CoV-2 infection (p = 0.606; Figure 3a).